Skip to main content
. 2019 Apr 4;2019(4):CD010880. doi: 10.1002/14651858.CD010880.pub2
Economic outcomes: 3e. Indirect cost (Euro): of medication (high = poor) – long term (skewed data)
Study Intervention Mean SD N
Prescribed
Castelein 2008 Peer support+ standard care 503 553 56
Castelein 2008 Standard care 504 460 50
Non‐prescribed
Castelein 2008 Peer support+ standard care 13 54 56
Castelein 2008 Standard care 6 32 50